Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | NSD2 | O96028 | 1/20 | 0.33 |
| ▸ | EGFR | P00533 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29353225 | 1.00 | HTR6 (0.36) | HTR6ALDH1A1NSD2EGFRLMNA | |
| SCHEMBL29354371 | 1.00 | HTR6 (0.36) | HTR6ALDH1A1NSD2EGFRLMNA | |
| SCHEMBL4988734 | 0.98 | HTR6 (0.34) | HTR6ALDH1A1NSD2EGFRLMNA | |
| Bromide SCHEMBL1030113 | 0.97 | HTR6 (0.35) | HTR6ALDH1A1NSD2EGFRLMNA | |
| SCHEMBL19469290 | 0.96 | HTR6 (0.34) | HTR6ALDH1A1NSD2EGFRLMNA | |
| SCHEMBL28174897 | 0.94 | HTR6 (0.33) | HTR6KCNN4 | |
| SCHEMBL1030115 | 0.94 | HTR6 (0.33) | HTR6 | |
| SCHEMBL2296753 | 0.93 | NPSR1 (0.33) | HTR6ALDH1A1LMNAMAPTKCNN4 | |
| SCHEMBL2512861 | 0.91 | HTR6 (0.32) | HTR6 | |
| SCHEMBL3129527 | 0.88 | HTR6 (0.36) | HTR6ALDH1A1NSD2EGFRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5122 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4725945-A1 | PREPARATION METHOD FOR FORMAMIDE COMPOUNDS | Shanghai Senhui Medicine Co., Ltd. (CN) | 2026-04-15 | — | — | EP | claimed |
| US-12577236-B2 | Processes for preparation of Tezacaftor | LAURUS LABS LIMITED (IN) | 2026-03-17 | — | — | US | claimed |
| US-20250206723-A1 | METHODS AND PROCESSES FOR THE PREPARATION OF MCT4 INHIBITORS | Vettore, LLC | 2025-06-26 | — | — | US | claimed |
| WO-2025081982-A1 | PREPARATION METHOD FOR FINERENONE KEY INTERMEDIATE | 山东诚创蓝海医药科技有限公司 | 2025-04-24 | — | — | WO | claimed |
| US-12233402-B2 | Cross-coupling reaction catalysts, and methods of making and using same | YALE UNIVERSITY (US) | 2025-02-25 | — | — | US | claimed |
| US-20250002519-A1 | NOVEL PRECATALYST SCAFFOLDS FOR CROSS-COUPLING REACTIONS, AND METHODS OF MAKING AND USING SAME | UNIV YALE (US) | 2025-01-02 | — | — | US | claimed |
| WO-2024251227-A1 | PREPARATION METHOD FOR FORMAMIDE COMPOUNDS | 上海森辉医药有限公司 | 2024-12-12 | — | — | WO | claimed |
| US-12122788-B2 | Process of making CFTR modulators | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2024-10-22 | — | — | US | claimed |
| US-20240327355-A1 | METHOD FOR PRODUCING ARYLAMIDE DERIVATIVE | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2024-10-03 | — | — | US | claimed |
| US-20240300922-A1 | PROCESS FOR PREPARING EGFR INHIBITORS | BLUEPRINT MEDICINES CORPORATION | 2024-09-12 | — | — | US | claimed |
| EP-1383734-A2 | COMPOUNDS USEFUL AS INTERMEDIATES FOR 4-AMINOQUINOLINE DERIVATIVES | Pfizer Products Inc. (US) | 2004-01-28 | — | — | EP | claimed |
| US-6664396-B1 | Reacting N,N'-unsubstituted quinacridone compound with haloaryl compound in presence of metal or metal compound to arylate N and N' positions and form corresponding N,N'-diarylquinacridone compound | EASTMAN KODAK COMPANY | 2003-12-16 | — | — | US | claimed |
| WO-2002088069-A9 | COMPOUNDS USEFUL AS INTERMEDIATES FOR 4-AMINOQUINOLINE DERIVATIVES | PFIZER PROD INC (US) | 2003-12-04 | — | — | WO | claimed |
| EP-1345889-A1 | METHOD FOR THE REGIOSELECTIVE PREPARATION OF SUBSTITUTED BENZO G]QUINOLINE-3-CARBONITRILES AND BENZO G]QUINAZOLINES | Wyeth (US) | 2003-09-24 | — | — | EP | claimed |
| US-20030144506-A1 | Processes for the preparation of substituted bicyclic derivatives for the treatment of abnormal cell growth | PFIZER INC. | 2003-07-31 | — | — | US | claimed |
| US-20030060624-A1 | Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic componunds | PFIZER INC. | 2003-03-27 | — | — | US | claimed |
| US-20020177716-A1 | Intermediates of CETP inhibitors | DAMON DAVID B (US) | 2002-11-28 | — | — | US | claimed |
| WO-2002088069-A2 | COMPOUNDS USEFUL AS INTERMEDIATES FOR 4-AMINOQUINOLINE DERIVATIVES | PFIZER PRODUCTS INC. (US) | 2002-11-07 | — | — | WO | claimed |
| WO-2002053528-A1 | METHOD FOR THE REGIOSELECTIVE PREPARATION OF SUBSTITUTED BENZO[G]QUINOLINE-3-CARBONITRILES AND BENZO[G]QUINAZOLINES | WYETH (US) | 2002-07-11 | — | — | WO | claimed |
| US-20020091273-A1 | Method for the regioselective preparation of substituted benzo[g]quinoline3-carbonitriles and benzo[g]quinazolines | AMERICAN HOME PRODUCTS CORPORATION | 2002-07-11 | — | — | US | claimed |